Patient-reported outcomes measures in generalized myasthenia gravis (gMG) are more important than ever, for both those ...

Caspian Oliai, MD, MS, medical director of the UCLA Bone Marrow Transplantation Stem Cell Processing Center, discusses ...

Mobile self-management programs like that offered by Hello Heart can benefit employers and patients alike as they seek to ...

After fine-tuning, the VGG16 convolutional neural network outperformed other deep learning models in 2 of 3 key ...

Social determinants of health been long understood to influence health outcomes, and this new analysis explores more deeply ...

Federal legislative and regulatory changes are reshaping pharmacy practice, with key challenges in government funding, ...

The Inflation Reduction Act (IRA) may be restricting Medicare Part D formularies, increasing patient costs, and stifling ...

In part 1 of this interview with Katrina Ortblad, ScD, MPH, she addressed bridging gaps in HIV care with pharmacy-based ...

Neha Kashalikar, PharmD, director of strategic pharmacy consulting, MassHealth, shares key components that makes a value-based contract successful.

Adam Colborn, JD, vice president for congressional affairs, AMCP, discusses key regulatory factors that managed care professionals must consider when implementing artificial intelligence (AI) in ...

Prior authorizations create substantial administrative and financial burdens on physicians and patients and can disrupt the continuity of care.

Janus kinase (JAK) inhibitors, including ruxolitinib cream and abrocitinib, demonstrate strong efficacy in atopic dermatitis ...